This inventor holds 3 USPTO granted patents. Top assignee: Hoechst Roussel Pharmaceuticals. Active years: 1991-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1993
Title: The Innovative Contributions of Marc N Agnew
Introduction
Marc N Agnew is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at alleviating pain and memory dysfunctions.
Latest Patents
Agnew holds three patents, with his latest focusing on the process of preparing 2,6-methano-1,3-benzodiazocine compounds. These patents disclose novel 2,6-methano-1,3-benzodiazocines, intermediates, and processes for their preparation. They also detail methods for alleviating pain and addressing various memory dysfunctions, such as Alzheimer's disease, utilizing these compounds or compositions.
Career Highlights
Marc N Agnew is associated with Hoechst Roussel Pharmaceuticals, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the understanding and treatment of conditions characterized by decreased cholinergic function.
Collaborations
Agnew has collaborated with notable colleagues, including Richard C Allen and David M Fink, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Marc N Agnew's innovative work in the pharmaceutical industry highlights his commitment to improving health outcomes through scientific advancements. His patents and collaborations reflect a dedication to addressing critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile